The government today approved the inclusion of the intranasal Covid vaccine as a booster dose in the vaccination program for adults. Its addition to the list comes amid a spike in cases in China and some other countries.
Here’s a 5-point cheat sheet on nasal vaccines:
The Indian-made two-drop nasal vaccine iNCOVACC will be launched on the Co-WIN platform tonight.
The vaccine, produced by Bharat Biotech, is currently only available in private centres.
People who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster.
In a heterologous booster immunization, a person receives a different vaccine than the one used for the primary dose series.
The needle-free vaccine was approved by India’s Medicines Regulatory Agency in November, with restricted use in emergency situations.
Featured Video of the Day
Health minister’s warning to Rahul Gandhi’s Yatra: Politics under the guise of decorum?